bcl-6 in Lymphoma -- Sorting Out a Wastebasket?
- 14 July 1994
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (2) , 116-118
- https://doi.org/10.1056/nejm199407143310210
Abstract
Non-Hodgkin's lymphomas are a heterogeneous group of disorders. Approximately 85 percent of them originate from B lymphocytes, and these B-cell lymphomas fall into the following main groups: lymphocytic lymphoma, follicular-center-cell lymphoma, mantle-cell lymphoma, diffuse large-cell lymphoma, and Burkitt's lymphoma. The mucosa-associated lymphoid-tissue (MALT) lymphomas, which occur in mucosal sites such as the stomach, form a separate category and may have a large-cell morphology. Of these various types, about 40 percent are diffuse large-cell lymphomas. In addition to distinctive cell-surface markers, there are characteristic genetic abnormalities in some kinds of lymphoma (Figure 1). These genetic disturbances often follow breakage of chromosomes . . .Keywords
This publication has 15 references indexed in Scilit:
- Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell LymphomaNew England Journal of Medicine, 1994
- Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell LymphomaScience, 1993
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomasNature Genetics, 1993
- Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphomaBritish Journal of Cancer, 1993
- bcl-2 Rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical featuresCancer, 1993
- Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.Proceedings of the National Academy of Sciences, 1993
- Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.Journal of Clinical Oncology, 1991
- bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell LymphomaNew England Journal of Medicine, 1989
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982